IntraBio Inc. today announced positive topline results from its pivotal Phase III IB1001-303 clinical trial, "Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, ...

“They increase the quality of the muscle you build as opposed to just the size of the actual muscle.” ...

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing ...

BrandSpark, in partnership with Newsweek, is excited to present the 18th annual Best New Product Awards nominees.

Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

That’s only one problem. Your immune system also has an adaptive system of specialized immune cells and antibodies that attack and destroy invading microbes. This system remembers what those intruders ...

Myosteatosis is associated with poor outcomes in various liver diseases. However, standardized methods for assessing, defining, and diagnosing myosteatosis in the context of liver diseases remain ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of poor clinical outcomes ...

Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...

A Times investigation examines how Downtown LA Law Group, a firm at the center of L.A. County’s historic settlement over sex abuse in government facilities, rapidly amassed thousands of clients and ...